Evolva receives approval for Veri-teTM Resveratrol for animal health in Brazil


Reinach, 10 November 2022 – Evolva (SIX: EVE) a pioneer in the field of natural molecules and industrial biotech, has received approval for its Veri-teTM Resveratrol from the Brazilian Ministry of Agriculture, Livestock and Supply for animal nutrition and health, covering all animal species and all applications, including veterinary supplements.


The approval is an important milestone as it opens up exciting opportunities in the Brazilian market where Evolva already has regulatory approval for use of its Veri-teTM Resveratrol for use in dietary supplements for humans. Under the branding of Veri-teTM PETS, the formulations will be marketed by Evolva’s existing Brazilian distribution partner, Tovani Benzaquen Ingredients (”Tovani”).


Anne De Vos, Chief Commercial Officer of Evolva, comments: ”Following initial sales with our Veri-teTM Resveratrol product offering for use in dietary supplements for humans, the approval and registration for use in dietary supplements and feed for all animal species significantly expands the addressable market for us in Brazil. Veri-teTM Resveratrol today is the main pillar of Evolva’s Health Ingredients business and a key contributor to our ambition to significantly boost growth. We will work with our trusted partner Tovani to jointly address this additional market potential.”